CO5611116A2 - Proceso para la produccion de acido 6 alfa, 9 alfa-diflururo 17 alfa-(1-oxopropoxi)-11 beta-hidroxi-16 alfa-metil-3-oxo- androsta-1,4-dien-17 beta-carbotioico - Google Patents
Proceso para la produccion de acido 6 alfa, 9 alfa-diflururo 17 alfa-(1-oxopropoxi)-11 beta-hidroxi-16 alfa-metil-3-oxo- androsta-1,4-dien-17 beta-carbotioicoInfo
- Publication number
- CO5611116A2 CO5611116A2 CO04074015A CO04074015A CO5611116A2 CO 5611116 A2 CO5611116 A2 CO 5611116A2 CO 04074015 A CO04074015 A CO 04074015A CO 04074015 A CO04074015 A CO 04074015A CO 5611116 A2 CO5611116 A2 CO 5611116A2
- Authority
- CO
- Colombia
- Prior art keywords
- alfa
- beta
- compound
- formula
- oxopropoxi
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
- C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
- A61P5/44—Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
1.- Un proceso para preparar un compuesto de fórmula (II) o una sal del mismo que comprende:(a) hacer reaccionar un compuesto de fórmula (III)con un derivado activado de ácido propiónico en una cantidad de al menos 1,3 moles del derivado activado por mol de compuesto de fórmula (III) y;(b) eliminar el resto propionilo ligado a azufre de cualquier compuesto de fórmula (IIA) así formado mediante la reacción del producto de la etapa (a) con una base amina orgánica primaria o secundaria capaz de formar una propanamida soluble en agua.10.- Un compuesto de fórmula (II) aislado en forma de una sal sólida cristalina.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0202563.3A GB0202563D0 (en) | 2002-02-04 | 2002-02-04 | Process |
Publications (1)
Publication Number | Publication Date |
---|---|
CO5611116A2 true CO5611116A2 (es) | 2006-02-28 |
Family
ID=9930365
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CO04074015A CO5611116A2 (es) | 2002-02-04 | 2004-07-30 | Proceso para la produccion de acido 6 alfa, 9 alfa-diflururo 17 alfa-(1-oxopropoxi)-11 beta-hidroxi-16 alfa-metil-3-oxo- androsta-1,4-dien-17 beta-carbotioico |
Country Status (22)
Country | Link |
---|---|
US (1) | US20050080065A1 (es) |
EP (1) | EP1472271A1 (es) |
JP (1) | JP2005521680A (es) |
KR (1) | KR20040088050A (es) |
CN (1) | CN1628125A (es) |
AR (1) | AR038389A1 (es) |
AU (1) | AU2003206837B2 (es) |
BR (1) | BR0307352A (es) |
CA (1) | CA2473753A1 (es) |
CO (1) | CO5611116A2 (es) |
GB (1) | GB0202563D0 (es) |
IL (1) | IL162919A0 (es) |
IS (1) | IS7350A (es) |
MX (1) | MXPA04007529A (es) |
MY (1) | MY140446A (es) |
NO (1) | NO20043665L (es) |
NZ (1) | NZ534044A (es) |
PL (1) | PL372217A1 (es) |
RU (1) | RU2333217C2 (es) |
TW (1) | TW200307689A (es) |
WO (1) | WO2003066654A1 (es) |
ZA (1) | ZA200405515B (es) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL153462A0 (en) * | 2002-12-16 | 2003-07-06 | Chemagis Ltd | Thiocarboxylic acid organic salts and processes utilizing the same |
PT103202B (pt) | 2004-10-19 | 2011-01-27 | Hovione Farmaciencia S A | Processo para a esterificação de um ácido carbotiótico |
CN100560598C (zh) * | 2005-07-26 | 2009-11-18 | 上海奥锐特国际贸易有限公司 | 氟替卡松丙酸酯的合成方法 |
NO331891B1 (no) * | 2007-03-20 | 2012-04-30 | Clavis Pharma Asa | Kjemiske forbindelser, et farmasoytisk preparat inneholdende slike forbindelser, samt anvendelse derav for behandling av kreft, inflammasjon og KOLS |
US9303060B1 (en) * | 2014-10-03 | 2016-04-05 | Amphaster Pharmaceuticals, Inc. | Methods of preparing intermediate of fluticasone propionate |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2852505A (en) * | 1955-10-31 | 1958-09-16 | American Cyanamid Co | Aminodeoxyglycosidopurines |
US3288781A (en) * | 1964-12-18 | 1966-11-29 | Upjohn Co | Process for deacylating anhydro-lyxofuranosyl with nitrogen base |
US4500711A (en) * | 1977-03-21 | 1985-02-19 | Burroughs Wellcome Co. | Synthesis of leucovorin |
US4335121A (en) * | 1980-02-15 | 1982-06-15 | Glaxo Group Limited | Androstane carbothioates |
DK1059283T3 (da) * | 1999-06-11 | 2003-09-15 | Hoffmann La Roche | Fremgangsmåde til fremstilling af neuraminidase-inhibitor ro-64-0796 |
-
2002
- 2002-02-04 GB GBGB0202563.3A patent/GB0202563D0/en not_active Ceased
-
2003
- 2003-01-30 TW TW092102204A patent/TW200307689A/zh unknown
- 2003-01-31 MY MYPI20030363A patent/MY140446A/en unknown
- 2003-01-31 AR ARP030100298A patent/AR038389A1/es not_active Application Discontinuation
- 2003-02-03 JP JP2003566025A patent/JP2005521680A/ja active Pending
- 2003-02-03 WO PCT/EP2003/001116 patent/WO2003066654A1/en active Application Filing
- 2003-02-03 CA CA002473753A patent/CA2473753A1/en not_active Abandoned
- 2003-02-03 NZ NZ534044A patent/NZ534044A/en not_active Application Discontinuation
- 2003-02-03 RU RU2004121675/04A patent/RU2333217C2/ru not_active IP Right Cessation
- 2003-02-03 BR BR0307352-1A patent/BR0307352A/pt not_active IP Right Cessation
- 2003-02-03 AU AU2003206837A patent/AU2003206837B2/en not_active Expired - Fee Related
- 2003-02-03 EP EP03704542A patent/EP1472271A1/en not_active Withdrawn
- 2003-02-03 KR KR10-2004-7011942A patent/KR20040088050A/ko not_active Application Discontinuation
- 2003-02-03 US US10/502,684 patent/US20050080065A1/en not_active Abandoned
- 2003-02-03 MX MXPA04007529A patent/MXPA04007529A/es not_active Application Discontinuation
- 2003-02-03 CN CNA038032694A patent/CN1628125A/zh active Pending
- 2003-02-03 IL IL16291903A patent/IL162919A0/xx unknown
- 2003-02-03 PL PL03372217A patent/PL372217A1/xx not_active Application Discontinuation
-
2004
- 2004-07-09 IS IS7350A patent/IS7350A/is unknown
- 2004-07-12 ZA ZA200405515A patent/ZA200405515B/en unknown
- 2004-07-30 CO CO04074015A patent/CO5611116A2/es not_active Application Discontinuation
- 2004-09-01 NO NO20043665A patent/NO20043665L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
US20050080065A1 (en) | 2005-04-14 |
IL162919A0 (en) | 2005-11-20 |
RU2004121675A (ru) | 2005-05-27 |
NO20043665L (no) | 2004-09-01 |
JP2005521680A (ja) | 2005-07-21 |
TW200307689A (en) | 2003-12-16 |
BR0307352A (pt) | 2004-12-14 |
WO2003066654A1 (en) | 2003-08-14 |
AR038389A1 (es) | 2005-01-12 |
CA2473753A1 (en) | 2003-08-14 |
IS7350A (is) | 2004-07-09 |
MY140446A (en) | 2009-12-31 |
PL372217A1 (en) | 2005-07-11 |
ZA200405515B (en) | 2005-07-12 |
GB0202563D0 (en) | 2002-03-20 |
CN1628125A (zh) | 2005-06-15 |
RU2333217C2 (ru) | 2008-09-10 |
EP1472271A1 (en) | 2004-11-03 |
MXPA04007529A (es) | 2004-11-10 |
NZ534044A (en) | 2006-10-27 |
KR20040088050A (ko) | 2004-10-15 |
AU2003206837A1 (en) | 2003-09-02 |
AU2003206837B2 (en) | 2008-11-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR051778A2 (es) | Derivados del acido dimetilaminocrotonico y procesos para supreparacion | |
NI200500031A (es) | Nuevos procesos para la sintesis de ivabradine y ademas sales que la contienen con un acido aceptable farmaceuticamente. | |
CO5700735A2 (es) | Proceso para la preparacion de 2-cianopirrolidinas n-sustituidas | |
GB0418900D0 (en) | Novel salt forms | |
SE0200730L (sv) | Kristallin bas av citalopram | |
NZ598172A (en) | Synthesis of boronic ester and acid compounds | |
HK1052005A1 (en) | Percyquinnin, a process for its production and itsuse as a pharmaceutical. | |
CY1111277T1 (el) | Μεθοδος παραγωγης κιλοσταζολης | |
WO2006126035A3 (en) | Process for the preparation of rosuvastatin | |
FR2843114B1 (fr) | Procede de monomethylation d'heterocycles azotes | |
CO5611116A2 (es) | Proceso para la produccion de acido 6 alfa, 9 alfa-diflururo 17 alfa-(1-oxopropoxi)-11 beta-hidroxi-16 alfa-metil-3-oxo- androsta-1,4-dien-17 beta-carbotioico | |
ATE322487T1 (de) | Hydroxamsäure-derivate | |
UY30185A1 (es) | Método para la producción preferencial de isómeros geométricos y método de aislamiento | |
AR020620A1 (es) | Un procedimiento para preparar derivados del acido benzoico alquilados en posicion orto y el empleo del acido 4-cloro-2-metilbenzoico, preparado conforme adicho procedimiento, como producto intermedio en la sintesis de la n-diaminometilen-2-metil-4-(1-pirrolil)-5-metilsulfonilbenzamida y de la n-dia | |
AR087007A2 (es) | Proceso para preparar un derivado tiazolico intermediario en la sintesis de pesticidas de guanidina | |
ATE241589T1 (de) | Verfahren zur herstellung des neuraminidase- inhibitoren ro-64-0796 | |
AR041356A1 (es) | Un procedimiento para la sintesis industrial del diester metilico del acido 5- amino-3-carboximetil -4-ciano-2- tiofencarboxilico y aplicacion del mismo a la produccion industrial de sales bivalentes de acido ranelico y sus hidratos | |
ITMI20050833A1 (it) | Nuovo procedimento per la sintesi di aminoadamantani | |
MX2021000099A (es) | Sales de esteramina. | |
WO2003066653A3 (en) | Process for the production of fluticasone propionate, in particular of polymorphic form 1 | |
US2935439A (en) | Method of inhibiting growth of fungi | |
CO4980899A1 (es) | Proceso para la sintesis de los compuestos intermediarios de cloropurina | |
AR030258A1 (es) | Proceso para la preparacion de derivados de tiazol y compuestos relacionados | |
ES2303674T3 (es) | Procedimiento para la preparacion de 3-amino-8-(1-piperazinil)-2h-1-benzopiran-2-ona y sales e hidratos de la misma. | |
AR029393A1 (es) | Sales de un acido metilenbifosfonico sustituido o sin sustituir, proceso para prepararlas |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC | Application refused |